Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 2/20 | 0.42 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.42 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 7/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6614642 | 0.94 | SMN1; SMN2 (0.40) | ITGB1ITGA4ITGB7MAOAADRA1A | |
| SCHEMBL6614261 | 0.80 | MAPT (0.47) | MAOAADRA1AMAPTTP53SMN1; SMN2 | |
| SCHEMBL6617716 | 0.74 | MAOA (0.36) | ITGB1ITGA4ITGB7MAOAADRA1A | |
| SCHEMBL5734446 | 0.73 | HDAC6 (0.37) | MAPTTP53SMN1; SMN2 | |
| SCHEMBL3036063 | 0.73 | ALDH1A1 (0.40) | MAPT | |
| SCHEMBL5735580 | 0.71 | ACLY (0.39) | MAOAADRA1AMAPTTP53SMN1; SMN2 | |
| SCHEMBL5735982 | 0.70 | MAOA (0.37) | MAOAADRA1AMAPTTP53SMN1; SMN2 | |
| SCHEMBL19664253 | 0.70 | NPC1 (0.68) | MAPTTP53SMN1; SMN2POLB | |
| SCHEMBL27606518 | 0.70 | UTRN (0.34) | ITGB1ITGA4ITGB7MAOAADRA1A | |
| SCHEMBL6612158 | 0.70 | MAOA (0.62) | ITGB1ITGA4ITGB7MAOAADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100217007-A1 | CHEMICAL PROCESS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-08-26 | — | — | US | disclosed |
| EP-1928869-B1 | CHEMICAL PROCESS | SYNGENTA PARTICIPATIONS AG (CH) | 2010-03-17 | — | — | EP | disclosed |
| CN-101282970-A | Chemical process | SYNGENTA PARTICIPATIONS AG (CH) | 2008-10-08 | — | — | CN | disclosed |
| EP-1928869-A1 | CHEMICAL PROCESS | Syngeta Participations AG (CH) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007020460-A1 | CHEMICAL PROCESS | SYNGENTA PARTICIPATIONS AG (CH) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100217007-A1 | CHEMICAL PROCESS | CBR3, RCC2, CBR1 | ITGB1 2433/4885ITGA4 2722/4885ITGB7 1580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.